Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endothelial Progenitor Cells”

191 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 191 results

Testing effectiveness (Phase 2)Ended earlyNCT01543802
What this trial is testing

Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft-tissue
Heidelberg University 21
Not applicableStudy completedNCT05528809
What this trial is testing

Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic Sclerosis

Who this might be right for
Primary Gougerot-Sjögren SyndromeSystemic Sclerosis, Diffuse
University Hospital, Montpellier 40
Not applicableUnknownNCT02421081
What this trial is testing

Effect of Cell Surface Markers and Lymphoid Cell Distribution on the Arterial Tissue Repair (ECLAR)

Who this might be right for
Injury of Radial Artery at Wrist and Hand LevelInjury; Ulnar Artery, Hand and Wrist
TC Erciyes University 30
Large-scale testing (Phase 3)Study completedNCT01004406
What this trial is testing

Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I

Who this might be right for
Acute Coronary Syndrome
VA Office of Research and Development 59
Testing effectiveness (Phase 2)Study completedNCT00462436
What this trial is testing

Innovative Strategies For Risk Reduction Following CABG

Who this might be right for
Coronary Artery DiseaseType II Diabetes Mellitus
Unity Health Toronto 35
Not applicableStudy completedNCT02002104
What this trial is testing

Endothelialized ePTFE Graft by Nanobiotechnology

Who this might be right for
The Apparatus for Processing the Tubular Graft Modification Will be Designed and Evaluated.The On-site Capturing of the Endothelial (Progenitor) Cells by Peptide-mediated Selective Adhesion in Vitro and in Vivo Will Also be Elucidated.The Patency Rate of ITRI-made Artificial Blood Vessels Will be Evaluated by the Porcine Animal Model.
National Taiwan University Hospital
Early research (Phase 1)Looking for participantsNCT06359912
What this trial is testing

Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia

Who this might be right for
Critical Limb Ischemia
Allife Medical Science and Technology Co., Ltd. 27
Not applicableStudy completedNCT02982967
What this trial is testing

Recreational Physical Activity and Cardiometabolic Profile

Who this might be right for
Physical ActivityEndothelial DysfunctionMetabolic Syndrome x
Federal University of São Paulo 100
Testing effectiveness (Phase 2)Study completedNCT00208767
What this trial is testing

Effect of Valsartan on Carotid Artery Disease

Who this might be right for
Carotid Artery DiseasesAtherosclerosis
Emory University 120
Testing effectiveness (Phase 2)Study completedNCT01863914
What this trial is testing

Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula

Who this might be right for
End-stage Kidney DiseaseDiabetes MellitusArteriovenous Fistula
National Cheng-Kung University Hospital 60
Testing effectiveness (Phase 2)UnknownNCT00687648
What this trial is testing

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 70
Not applicableActive Not RecruitingNCT03216733
What this trial is testing

SORT OUT X - Combo Stent Versus ORSIRO Stent

Who this might be right for
Coronary Heart DiseaseAngina PectorisMyocardial Infarction
Aarhus University Hospital Skejby 3,148
Not applicableStudy completedNCT02117037
What this trial is testing

Prognostic Value of Biomarkers Associated With Endothelial Progenitor Cells Mobilization in Acute Coronary Syndromes

Who this might be right for
Acute Coronary Syndromes
Assistance Publique Hopitaux De Marseille 180
Not applicableStudy completedNCT00397592
What this trial is testing

Growth Hormone's Effect on Endothelial Progenitor Cells

Who this might be right for
Cardiovascular Disease
Vanderbilt University 18
Post-approval studies (Phase 4)UnknownNCT01155128
What this trial is testing

Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease

Who this might be right for
Cardiovascular DiseaseChronic Kidney DiseaseChronic Renal Disease+1 more
Federal University of Pelotas 200
Large-scale testing (Phase 3)Study completedNCT01067339
What this trial is testing

Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans

Who this might be right for
Endothelial Dysfunction
Mayo Clinic 70
Post-approval studies (Phase 4)Study completedNCT01617824
What this trial is testing

Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesChronic Renal Failure
University of Padova 45
Not applicableStudy completedNCT02263313
What this trial is testing

EGO-COMBO Clinical End-point Extension Study Beyond 36 Months

Who this might be right for
Coronary Restenosis
The University of Hong Kong 59
Large-scale testing (Phase 3)Study completedNCT02347098
What this trial is testing

Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II

Who this might be right for
Acute Coronary Artery Syndrome
VA Office of Research and Development 270
Post-approval studies (Phase 4)Study completedNCT02964585
What this trial is testing

Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
George Washington University 34
Load More Results
6